Efficacy, Safety and Tolerability of Propionyl-L-Carnitine Hydrochloride in Patients With Mild Ulcerative Colitis
Status:
Terminated
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
The aim of the trial is to test safety, tolerability and efficacy of Propionyl-L-carnitine
modified release tablets 1g/die in reducing the symptoms of the disease with respect to the
proportion of patients with disease remission at the end of the 8 weeks of treatment. It will
also aim to investigate capability of the treatment in the maintenance of remission after
four weeks of treatment interruption; histological changes will be also evaluated and
finally, improvement in the overall quality of life as measured by the Short Inflammatory
Bowel Disease Questionnaire (SIBDQ)will be investigated.